Horizon Therapeutics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Tim Walbert
Chief executive officer
US$20.1m
Total compensation
CEO salary percentage | 6.4% |
CEO tenure | 15.3yrs |
CEO ownership | n/a |
Management average tenure | 2.3yrs |
Board average tenure | 9.5yrs |
Recent management updates
Recent updates
These 4 Measures Indicate That Horizon Therapeutics (NASDAQ:HZNP) Is Using Debt Safely
Nov 25Do Horizon Therapeutics' (NASDAQ:HZNP) Earnings Warrant Your Attention?
Nov 02Horizon pays HemoShear milestone payment under pact to develop gout therapies
Sep 21Horizon Therapeutics announces $500M buyback program
Sep 09Horizon Therapeutics to expand footprint in Ireland
Aug 29Is Horizon Therapeutics (NASDAQ:HZNP) A Risky Investment?
Aug 22Horizon Therapeutics: This Core Biotech Company Is On Sale
Aug 19Analyst Forecasts Just Became More Bearish On Horizon Therapeutics Public Limited Company (NASDAQ:HZNP)
Aug 04Do Horizon Therapeutics' (NASDAQ:HZNP) Earnings Warrant Your Attention?
Aug 02Horizon Therapeutics: Buy The Dip For Slightly Risky, Catalyst Driven Growth
Jul 31Horizon gets FDA approval for Krystexxa's use with methotrexate for uncontrolled gout
Jul 08CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2023 | n/a | n/a | US$438m |
Mar 31 2023 | n/a | n/a | US$372m |
Dec 31 2022 | US$20m | US$1m | US$521m |
Sep 30 2022 | n/a | n/a | US$574m |
Jun 30 2022 | n/a | n/a | US$765m |
Mar 31 2022 | n/a | n/a | US$862m |
Dec 31 2021 | US$21m | US$1m | US$534m |
Sep 30 2021 | n/a | n/a | US$552m |
Jun 30 2021 | n/a | n/a | US$518m |
Mar 31 2021 | n/a | n/a | US$280m |
Dec 31 2020 | US$22m | US$1m | US$390m |
Sep 30 2020 | n/a | n/a | US$792m |
Jun 30 2020 | n/a | n/a | US$517m |
Mar 31 2020 | n/a | n/a | US$592m |
Dec 31 2019 | US$14m | US$1m | US$573m |
Sep 30 2019 | n/a | n/a | US$82m |
Jun 30 2019 | n/a | n/a | US$97m |
Mar 31 2019 | n/a | n/a | US$77m |
Dec 31 2018 | US$17m | US$1m | -US$38m |
Sep 30 2018 | n/a | n/a | -US$178m |
Jun 30 2018 | n/a | n/a | -US$275m |
Mar 31 2018 | n/a | n/a | -US$460m |
Dec 31 2017 | US$2m | US$1m | -US$350m |
Sep 30 2017 | n/a | n/a | -US$495m |
Jun 30 2017 | n/a | n/a | -US$437m |
Mar 31 2017 | n/a | n/a | -US$212m |
Dec 31 2016 | US$2m | US$950k | -US$166m |
Compensation vs Market: Tim's total compensation ($USD20.10M) is above average for companies of similar size in the US market ($USD12.14M).
Compensation vs Earnings: Tim's compensation has been consistent with company performance over the past year.
CEO
Tim Walbert (56 yo)
15.3yrs
Tenure
US$20,103,869
Compensation
Mr. Timothy P. Walbert, also known as Tim, serves as an Independent Director at Mirum Pharmaceuticals, Inc. from April 05, 2023. He is an Independent Director of Century Therapeutics, Inc. since September...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 15.3yrs | US$20.10m | no data | |
Executive VP of Finance & CFO | 1.4yrs | US$7.17m | 0% $ 0 | |
Executive VP & General Counsel | 1.7yrs | US$10.87m | 0% $ 0 | |
Executive VP & Chief Strategy Officer | 3.9yrs | US$6.75m | 0% $ 0 | |
Executive Vice President of Research & Development | 2.6yrs | US$8.48m | 0% $ 0 | |
Senior VP & Chief Accounting Officer | less than a year | no data | 0% $ 0 | |
Senior VP & Chief Investor Relations Officer | no data | no data | no data | |
Executive VP of Corporate Affairs & Chief Communications Officer | 7.8yrs | no data | no data | |
Executive VP & Chief Marketing Officer | less than a year | no data | no data | |
Senior VP of Corporate Development & Chief of Staff | 2yrs | no data | no data | |
Executive VP | 6.1yrs | US$2.31m | no data | |
Executive VP & Chief Medical Officer | no data | US$5.86m | 0% $ 0 |
2.3yrs
Average Tenure
48yo
Average Age
Experienced Management: HZNP's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman | 15.3yrs | US$20.10m | no data | |
Lead Independent Director | 12.1yrs | US$551.24k | 0% $ 0 | |
Independent Director | 9.1yrs | US$522.49k | 0% $ 0 | |
Independent Director | 16.3yrs | US$504.36k | 0% $ 0 | |
Independent Director | 11.6yrs | US$494.99k | 0% $ 0 | |
Independent Director | 9.5yrs | US$506.24k | 0% $ 0 | |
Independent Director | 6.2yrs | US$510.61k | 0% $ 0 | |
Independent Director | 4.2yrs | US$514.36k | 0% $ 0 | |
Independent Director | 6.2yrs | US$496.24k | 0% $ 0 |
9.5yrs
Average Tenure
66yo
Average Age
Experienced Board: HZNP's board of directors are considered experienced (9.5 years average tenure).